Navigation Links
Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimer's Disease and Cognitive Decline
Date:10/12/2010

ANN ARBOR, Mich., Oct. 12 /PRNewswire/ -- Adeona Pharmaceuticals, Inc., (Amex: AEN) announced five scientific publications on the role of copper toxicity and zinc deficiency in Alzheimer's disease and cognitive decline. The author of all these publications is Adeona's scientific founder and consultant, George J. Brewer, M.D., the Morton S. and Henrietta Sellner Emeritus Professor of Human Genetics and Internal Medicine at the University of Michigan.

The first two publications describe the results of Adeona's observational clinical study of zinc and copper status in 29 patients with Alzheimer's disease, 30 patients with Parkinson's disease, and 29 age- and sex-matched controls (CopperProof-1). The CopperProof-1 study was conducted at Albany Medical Center by Earl Zimmerman, M.D., Director of the Alzheimer's Centers, Eric Molho, M.D., Director of the Parkinson's Disease Centers and Dzintra Celmins, M.D., of the Parkinson's Disease Centers.

The first publication entitled, "Subclinical Zinc Deficiency in Alzheimer's Disease and Parkinson's Disease," was published in the November 2010 issue of the American Journal of Alzheimer's Disease & Other Dementias. Serum zinc and urinary zinc were compared across the three groups of patients. The results showed a significantly lower serum zinc level in patients with Alzheimer's and patients with Parkinson's than in controls.

The second publication entitled, "Copper and Ceruloplasmin Abnormalities in Alzheimer's Disease," was published in the September 2010 issue of the American Journal of Alzheimer's Disease and Other Dementias. That publication describes how copper may play a role in the pathogenesis of Alzheimer's disease and increased exposure to environmental copper and/or defective ceruloplasmin function could directly be contributing to the Alzheimer's epidemic.  

Since the initial presenta
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Adeona Announces Second Quarter 2010 Profitability and Achievements
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Adeona Announces HartLab Expansion Into Microbiology Testing Services
4. Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
5. Gen-Probe Announces Webcast of Third Quarter 2010 Earnings Conference Call
6. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
7. Pioneer® Surgical Technology, Inc. Announces Plans to Establish Manufacturing and Distribution Facility in Ireland
8. Webcast Alert: CEL-SCI Corp. (CVM) Announces the Biotech, Healthcare and Pharma Virtual Conference
9. IRIDEX Announces Commercial Availability of New Adjustable & Intuitive EndoProbe® Device for Eye Surgery
10. TriReme Medical Announces $17 Million Series D Financing
11. Warner Chilcott Announces FDA Approval of Next Generation Actonel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Radiology Information Systems Market by Type, Deployment Mode, ... Forecast to 2019" report to their offering. ... estimated at $501.1 Million 2014, and is projected to ... 7.6% from 2014 to 2019. The ...
(Date:9/3/2015)... -- The findings of a year-long investigation conducted by NBC ... handling of its Recovery IVC filter product ... part one of the series revealed that ... fatalities, have been associated with the Recovery device. NBC ... Bard in 2004 which linked the Recovery IVC filter ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... announced the addition of the "Investigation Report on ... As air pollution worsens, the incidence of ... size of relevant drugs. Bromhexine, a semisynthetic derivative of ... of chronic bronchitis and asthma associated with viscid or ...
Breaking Medicine Technology:Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 2Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry 3IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3China Bromhexine Market Report 2015-2019 2
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), ... (ESI) announced the selection of its,disinfectant, EnviroTru(TM) ... Authority (Metro). EnviroTru(TM) is a multi-purpose ... and also meets EPA requirements for,Toxicity Category ...
... Presented at Anti-Angiogenesis Conference Shows R84, the Selective Human ... Affitech, Is Equivalent to Avastin in Inhibiting Growth of Established ... Tumors in a Preclinical Breast Cancer Model -- ... a Potential Clinical Candidate --, BOSTON and TUSTIN, Calif., ...
Cached Medicine Technology:Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 3New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 2New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 3New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 4New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models 5
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... William Mattar ... William Mattar, Esq. believes this does not stop at any certain demographic or segment ... its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The closed captioning ...
(Date:9/3/2015)... ... 03, 2015 , ... Topical BioMedics, Inc., hosted Amsterdam resident ... six-month, 10,000 mile journey from Santiago, Chile to Times Square and then Rhinebeck, ... Las Americas” project—Max crossed six countries in 168 days on his 39-year-old Moto ...
(Date:9/3/2015)... ... September 03, 2015 , ... Silverado next week lays ... Columbine Drive in Bellingham, Washington. Silverado Bellingham, a 41,000 square foot, single-story community, ... serve up to 80 people living with Alzheimer’s, dementia and other memory-impairing conditions. ...
(Date:9/3/2015)... ... September 03, 2015 , ... RealtyShares , the online ... institutional investors to real estate investment opportunities nationwide, today announced that it is ... investors and sponsoring real estate companies. , These products typically involve ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private companies ... "only a tiny fraction of the nation's companies have demonstrated such remarkably consistent ...
Breaking Medicine News(10 mins):Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2
... and Caitlin Mason from Queens University, Canada has reported in ... national surveys which reported the obesity// and overweight in Canadian ... between 1985 to 2003. The study showed an increasing trend ... a shift in BMI index from Class II to Class ...
... like that of viral flu are spreading across Delhi with ... a minimum of 0.2 degrees Celsius (7 degrees below normal) ... reached 11.6 degrees //(five degree above normal) on 17 January ... the weather change. ,‘There is a sudden ...
... approved the drug for use to treat the cancer multiple ... the Department of Health and Ageing. It is available through ... is to go to the PBS," as said by the ... the drug was originally used in Australia in the late ...
... died in Singapore a few days after the operation, and ... is reported to have suffered from a heart attack while ... transplant surgeon K.C. Tan. ,The recipient, a ... enough to go home. Tan said the donor was put ...
... of Science throws light on cells that could prevent ... in the February issue of Nature Neuroscience. ... led the study, //which might have important implication in ... The researchers say that immune cells play a key ...
... 39-year-old Mogjan Azari, a dentist who was jailed for one ... and is banned from practicisig. Azari allowed her boyfriend Omid ... devastating consequences. ,Mazaheri practiced on Azari's patients without ... days. On one occasion he broke a syringe in a ...
Cached Medicine News:Health News:Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function 2
Farabeuf periosteal elevators....
OHL periosteal elevator, 19 cm, 7-1/2"....
Steinhauser periosteal elevator....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Medicine Products: